Abstract
Innate immune cells, such as macrophages, respond to pathogen-associated molecular patterns, such as a lipopolysaccharide (LPS), to secrete various inflammatory mediators. Recent studies have suggested that damage-associated molecular patterns (DAMPs), released extracellularly from damaged or immune cells, also play a role in the activation of inflammatory responses. In this study, to prevent excess inflammation, we focused on DAMPs-mediated signaling that promotes LPS-stimulated inflammatory responses, especially adenosine 5’-triphosphate (ATP)-triggered signaling through the ionotropic purinergic receptor 7 (P2X7R), as a potential new anti-inflammatory target of natural polyphenols. We focused on the phenomenon that ATP accelerates the production of inflammatory mediators, such as nitric oxide, in LPS-stimulated J774.1 mouse macrophages. Using an siRNA-mediated knockdown and specific antagonist, it was found that the ATP-induced enhanced inflammatory responses were mediated through P2X7R. We then screened 42 polyphenols for inhibiting the ATP/P2X7R-induced calcium influx, and found that several polyphenols exhibited significant inhibitory effects. Especially, a flavonoid baicalein significantly inhibited ATP-induced inflammation, including interleukin-1β secretion, through inhibition of the ATP/P2X7R signaling. These findings suggest that ATP/P2X7R signaling plays an important role in excess inflammatory responses and could be a potential anti-inflammatory target of natural polyphenolic compounds.
Introduction
Inflammation is an essential immune response that enables survival during infection or injury and maintains tissue homeostasis. Under noxious or abnormal conditions, several inflammatory mediators, including cytokines, chemokines, reactive gases, and eicosanoids, produced by immune cells attract other leukocytes to the injured and/or infected tissues to exclude foreign substances through phagocytosis, killing effects, and cell death induction [1–3]. Therefore, inflammation is important for host defense or tissue remodeling. However, abnormal inflammation with over or persistent expression of mediators could lead to the initiation and progression of various diseases, such as type 2 diabetes [4], cardiovascular diseases [5–7], neurodegenerative diseases [8,9], and cancers [10]. Inflammation is triggered not only by pathogen-associated molecular pattern molecules (PAMPs) derived from microorganisms, such as a lipopolysaccharide (LPS), but also by damage-associated molecular patterns (DAMPs), either actively or passively released from damaged or immune cells, such as uric acid crystals, nucleotides, and the chromatin-associated protein HMGB1. Recent studies have suggested that DAMPs could be implicated in excessive inflammation which plays a key role in the pathogenesis of several diseases, and therefore targeting DAMPs or their receptors might be beneficial [11,12]. In addition, Yang et al. reported the importance of therapeutic approaches to selectively target DAMPs-mediated inflammation while preserving physiological protective immune responses, such as PAMPs-elicited inflammatory responses [13].
Adenosine-5’-triphosphate (ATP) is present at high levels (5–8 mM) in the cytoplasm for cellular homeostasis [14,15], and is released through multiple pathways, including the membrane degradation of necrotic cells, connexin hemichannels from immune cells, pannexin hemichannels from apoptotic cells [16], lysosomal exocytosis from dying cells depending on autophagy [17], and vesicular exocytosis from epithelial cells and osteoblasts and nerves [14]. It is suggested that released extracellular ATP has important and diverse effects on many biological processes including inflammasome formation, promoting cytokine release, pain, defective phagocytic clearance, smooth muscle contraction, and neurotransmission [18–20]. These effects are mediated by plasma membrane purinergic receptors comprised of ATP-gated ionotropic P2Xs and guanine nucleotide-binding protein-coupled P2Ys. On the other hand, many researchers have pointed out that extracellular ATP, released from injured or damaged cells under abnormal conditions, causes undesirable responses to the surrounding cells. For example, the ATP levels of bronchoalveolar lavage fluid are increased by smoking, and the extracellular ATP contributes to the pathogenesis of chronic obstructive pulmonary disease [21], lung fibrosis [22], and allergic asthma [23]. Studies using knockout or antagonists of the ionotropic purinergic receptor 7 (P2X7R), preferentially expressed in immune cells, suggested that P2X7R activation by extracellular ATP is linked to colitis [24], systemic lupus erythematosus and rheumatoid arthritis [25], coronary artery diseases [26], short survival during infection [27], and the progression of brain tumors [28]. Recent findings also suggest that P2X7R-mediated ATP signaling may represent a potential therapeutic target to improve health and that natural products or synthetic compounds inhibiting P2X7R could be useful in clinical trials [29,30].
Many reports have suggested that natural polyphenols, present in vegetables or fruits, have potential health-beneficial effects including anti-inflammatory effects through a variety of biological activities, such as antioxidant and radical scavenging activities, regulation of intracellular signaling cascades or transcriptional networks, and improvements of the endothelial structure or function [31,32]. It has been reported that natural polyphenols down-regulate PAMPs-induced inflammatory mediators, such as LPS-induced pro-inflammatory cytokines, both in vitro and in vivo [32,33]. Toll-like receptor 4 (TLR4) and other pathogens recognition receptors-induced mitogen-activated protein kinases (MAPKs) and nuclear factor κB (NF-κB) pathways were shown to be important targets for polyphenols, such as quercetin [34], epigallocatechin gallate (EGCG) [35], luteolin [36], apigenin [37], and others [38,39]. However, it still remains unknown whether DAMPs-mediated excess inflammatory responses could be the target of natural compounds including polyphenols.
In this study, to develop a new strategy for the prevention of inflammatory diseases, we investigated the molecular actions of extracellular ATP on the LPS-induced macrophage inflammation and carried out screening of natural polyphenols for the inhibition of ATP signaling. We propose that P2X7R-mediated ATP signaling could be a potential anti-inflammatory target of natural polyphenols.
Materials and methods
Reagents
Dulbecco's modified eagle medium (DMEM, 4.5 g/l glucose, liquid), penicillin-streptomycin mixed solution (Stabilized), ATP disodium salt hydrate from yeast, adenosine-5'-diphosphate (ADP) sodium salt from a bacterial source, adenosine-5'-monophosphate (AMP) sodium salt from yeast, apyrase from potato, protease inhibitor cocktail, phosphatase inhibitor cocktail, bovine serum albumin (BSA, F-V), and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) were obtained from Nacalai Tesque, Inc. (Kyoto, Japan). Fetal bovine serum (FBS) and LPS from Escherichia coli O127:B8 were obtained from the Sigma-Aldrich (St. Louis, USA). DMEM without phenol red (4.5 g/l glucose, liquid), sulfanilamide, N-(1-naphthyl)ethylenediamine dihydrochloride, sodium nitrite, and rabbit IgG were obtained from Wako Pure Chemical Industries (Osaka, Japan). Rabbit polyclonal antibody to inducible nitric oxide synthase (iNOS) (sc-650) and mouse monoclonal antibody to β-actin (sc-47778) were obtained from Santa Cruz Biotechnology, Inc. (Texas, USA). Rabbit polyclonal antibody to P2X7R was obtained from GeneTex, Inc. (LA, USA). Rabbit monoclonal antibodies to phospho-signal transducer and activator of transcription (STAT) 1 (Tyr701) (58D6), phospho-interferon regulatory factor (IRF)-3 (Ser396) (4D4G), phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP, phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP, rabbit polyclonal antibody to phospho-stress-activated protein kinases (SAPKs)/c-jun N-terminal kinases (JNKs) (Thr183/Tyr185), and mouse monoclonal antibody to inhibitor κB (IκB)-α were obtained from Cell Signaling Technology, Inc. (MA, USA). Rabbit polyclonal antibody to mouse interferon (IFN)-β for neutralization was obtained from Pestka Biomedical Laboratories, Inc. (NJ, USA). BAPTA-AM was obtained from Invitrogen (CA, USA). Fluo 4-AM was obtained from Dojindo Laboratories (Kumamoto, Japan). 4-(N,N-Dipropylsulfamoyl) benzoic acid (probenecid) was obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Pluronic F-127 was obtained from Life Technologies Japan, Ltd. (Tokyo, Japan). All other chemicals were commercially available analytical grade reagents. TAK-242 was obtained from Merck.
Cell culture
Murine macrophage-like J774.1 cells were obtained from American Tissue Culture Collection, and cultured in DMEM, which contains glucose (4.5 mg/ml) and L-glutamine (584 μg/ml), supplemented with 10% heat-inactivated FBS, penicillin (100 units/ml), and streptomycin (100 μg/ml) at 37°C under 5% CO2.
Transfection of siRNA
Stealth RNAi siRNA against P2X7R (P2rx7 MSS276199) and a negative control (low GC) were obtained from Invitrogen (CA, USA). The transfection of siRNA was performed using the Neon Transfection System (Life Technologies Japan, Ltd., Tokyo, Japan). J774.1 cells (2 × 106 cells) were resuspended in 100 μl resuspension buffer R containing 50 nM siRNA against P2X7R or control siRNA and transfected in 100 μl Neon tip using two pulses (1720 V input pulse voltage, 10 ms input pulse width). The transfected cells were seeded into 24-well plates (5 ×105 cells/well) and cultured in antibiotic-free DMEM for 24–36 h, then used for each experiment.
Measurement of nitric oxide production
Nitric oxide (NO) production was evaluated by measuring the metabolite nitrite (NO2-) using the Griess assay. J774.1 cells were seeded into 48-well plates and cultured overnight. After washing with phosphate-buffered saline (PBS), the medium was replaced with phenol red-free DMEM containing LPS (1 μg/ml) and adenosine analogs (1 mM). After incubation for 24 h, each cultured medium (100 μl) was mixed with 100 μl of Griess reagent [1% (w/v) sulfanilamide in 5% (w/w) phosphoric acid and 0.1% (w/v) N-(1-naphthyl)ethylenediamine dihydrochloride in water]. The optical density was then measured at 550 nm. The nitrite levels were calculated using a standard curve derived from authentic sodium nitrite.
Western blotting
J774.1 cells were seeded into 24-well plates and cultured overnight. After treatment with each agent for the indicated times, the cells were washed with PBS and lysed with a radio-immunoprecipitation assay buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 0.1% sodium dodecyl sulfate (SDS), 1 mM ethylenediaminetetraacetic acid] supplemented with both protease and phosphatase inhibitor cocktails. The protein concentrations were determined by a Protein Assay Bicinchoninate Kit (Nacalai Tesque, Kyoto, Japan). The protein samples were denatured by heating at 95°C for 5 min in the presence of SDS (2%) and 2-mercaptoethanol (5%), then separated using 10% SDS-polyacrylamide gels followed by a semi-dry blotting onto a polyvinylidene difluoride membrane (Hybond P, GE Healthcare). After blocking with EzBlock Chemi (Atto Corp., Tokyo, Japan) in Tris-buffered saline containing 0.05% Tween 20 (TTBS) at room temperature for 30 min, the membrane was washed with TTBS, then incubated overnight with a primary antibody (1:1000) in TTBS containing 5% BSA at 4°C. After washing, the membrane was incubated with horseradish peroxidase-conjugated secondary antibody (1:2000) in TTBS containing 5% skim milk at room temperature for 1 h. After washing, chemiluminescent detection was performed using Chemi-Lumi One L or Chemi-Lumi One Super (Nacalai Tesque, Kyoto, Japan) and visualized by Ez-Capture MG (Atto Corp., Tokyo, Japan).
Real-time reverse transcription-polymerase chain reaction
The total RNA was extracted from the cells using Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, Japan). cDNA was synthesized using ReverTra Ace qPCR RT Master Mix with gDNA Remover (Code No. FSQ-301, Toyobo Co., Ltd., Osaka, Japan). PCR amplification was performed with THUNDERBIRD SYBR qPCR Mix (Code No. QPS-201, Toyobo Co., Ltd., Osaka, Japan) using the LightCycler Nano System (Roche Diagnostics K.K., Tokyo, Japan). The relative expression of each mRNA was calculated according to the 2-ΔΔCt method and normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. The primer sequences are listed in the S1 Table.
Measurement of calcium influx
Cells were seeded into 48-well plates and cultured overnight. After washing with PBS, the medium was replaced with phenol red-free DMEM containing Fluo 4-AM (5 μg/ml), Pluronic F-127 (0.02%), and probenecid (1.25 mM). After incubation for 1 h, the medium was replaced with phenol red-free DMEM containing each polyphenol (50 μM) and probenecid (1.25 mM). After incubation for 10 min, an equal volume of phenol red-free DMEM containing ATP (4 mM) and the corresponding polyphenol (50 μM) was added to each well. After incubation for 10 min, the cell plates were scanned using Typhoon FLA 9500 at the following settings: 473 nm blue LD laser, BPB1 emission filter, 500 V photomultiplier, 100-μm pixel size. The fluorescence intensity of each well was measured using Image Quant TL ver. 8.1.
Cytotoxicity assay
Cells were seeded into 48-well plates and cultured overnight. After each stimulation, the medium was replaced with DMEM containing MTT (0.2 mg/ml) and incubated for 30 min. After removing the medium, the formazan was dissolved in dimethyl sulfoxide (200 μl/well) and the optical density was measured at 550 nm. The relative cell viability was calculated using the following formula: relative cell viability (%) = optical density of experimental groups / optical density of the control group × 100.
ELISA for murine interleukin-1β
The amount of interleukin-1β (IL-1β) was determined according to the recommended protocol for the ELISA Development Kit for murine IL-1β (Peprotech, USA). Colorimetric detection was performed using the TMB Substrate Reagent Set (BD Biosciences, USA). The reaction was terminated by adding 2N sulfuric acid and the optical density was measured at 450 nm.
Statistics
The data represent means ± S.D. of triplicate determinations. All the statistical analyses were performed by Tukey-Kramer method. The asterisks indicate statistical significance (P < 0.05).
Results
ATP accelerates NO production in LPS-stimulated J774.1 mouse macrophages
To examine the effects of ATP on the macrophage inflammation, J774.1 cells were treated with LPS in the presence or absence of ATP for 12–36 h. We observed that the LPS-induced NO production was enhanced after 24 h in the presence of ATP, although NO production was not induced by ATP alone (Fig 1A and Figure A in S1 Fig). The cell viability was not affected by the ATP (Figure B in S1 Fig). Both the protein and mRNA expressions of iNOS, a key enzyme generating NO, were also up-regulated by the addition of ATP (Fig 1B and 1C), but not by ATP alone (Figure C in S1 Fig). Given that the extracellular ATP is rapidly degraded by ectonucleotidases, such as CD39 [40,41], we investigated whether the NO production could certainly be enhanced by ATP, or the degradation products. As shown in Fig 1D, the enhanced NO production by ATP was abolished by the treatment with apyrase, an enzyme that hydrolyzes ATP into AMP. We also confirmed that ADP and AMP did not enhance the LPS-induced NO production (Figure D in S1 Fig).
ATP facilitates IFN-β expression to enhance the NO production
To investigate the molecular mechanisms of the ATP-enhanced NO production, we analyzed the upstream signaling pathway regulating the iNOS transcription. As it is reported that secreted interferons are necessary for full expression of the iNOS mRNA [42,43], we evaluated the involvement of IFN-β, expressed strongly in J774.1 cells, in the LPS/ATP-induced expression of iNOS. As shown in Fig 2A, the addition of anti-IFN-β neutralizing antibody almost completely suppressed the LPS-induced iNOS protein expression in both presence and absence of ATP, suggesting the involvement of autocrine/paracrine signaling of IFN-β in LPS-induced iNOS expression. Indeed, consistent with the induction of iNOS, ATP enhanced the LPS-induced IFN-β mRNA expression and phosphorylation of STAT1, downstream of the IFN-β signaling (Figs 2B and 2C). In addition, the phosphorylation of IRF-3, the essential transcription factor of IFN-β [44], was also up-regulated by the addition of ATP (Fig 2D).
P2X7R activation up-regulates IFN-β expression and NO production
It has been reported that P2X7R, expressed on most immune cells, such as macrophages, is activated through millimolar concentrations of extracellular ATP (0.1–4 mM) and participates in inflammation and pain mechanisms [30,45–48]. Therefore, we next examined the involvement of P2X7R in the enhancement of the LPS-induced inflammation by ATP. As shown in Fig 3A, LPS-induced NO production, especially in the presence of ATP, was significantly reduced in the P2X7R knockdown cells, showing the effects of ATP through P2X7R activation. Since the activated P2X7R has been shown to facilitate the influx of extracellular cations, including calcium ions (Ca2+) [48,49], we next investigated the roles of the Ca2+ influx in the LPS/ATP-induced IFN-β expression. As shown in Fig 3B, BAPTA-AM, an intracellular Ca2+ chelator, significantly inhibited the LPS/ATP-induced IFN-β expression. In addition, A23187, a Ca2+ ionophore, also reproduced the enhancing effect of ATP on the IFN-β expression (Fig 3C). We confirmed that the Ca2+ influx, monitored using Fluo 4-AM, was induced by the treatment of ATP for 10 min and was abrogated in the P2X7R knockdown cells (Fig 3D). These results strongly suggest that the ATP/P2X7R-mediated Ca2+ influx contributes to the LPS/ATP-induced IFN-β expression.
P2X7R-mediated ATP signaling affects TLR4 signaling to enhance IFN-β expression and NO production
Next, to understand the actions of ATP on enhanced inflammation, we examined the timing of the ATP stimulation for enhancing LPS-induced NO production. As shown in Fig 4A, we found that the LPS-induced NO production was enhanced only when cells were co-treated with LPS and ATP, but hardly affected when ATP was added a few hours after the LPS stimulation. This result suggested that the P2X7R-mediated ATP signaling stimulated upstream of the LPS-induced TLR4 signaling. As shown in Fig 4B, ATP-enhanced NO production in LPS-treated cells was not observed in the presence of a specific TLR4 inhibitor TAK-242, showing the effects of ATP on the TLR4 signaling. We then investigated whether ATP could activate the LPS/TLR4 signaling pathways, such as NF-κB and MAPKs pathways. As shown in Fig 4C, the LPS-induced degradation of IκB-α and phosphorylation of ERK and JNK at 30 min were up-regulated by ATP. Phosphorylation of p38 was not affected by ATP. The phosphorylation of ERK was also induced by ATP alone. It was reported that the activation of these pathways results in the activation of the downstream transcription factors, such as NF-κB and activator protein-1, to induce the IFN-β and iNOS mRNA expression [42,43,50]. In addition, it has been reported that the P2X7R activation induces ERK phosphorylation via Ca2+-dependent or -independent activation of the upstream kinases [51–53]. We then investigated the involvement of the ERK phosphorylation on the effects of ATP. As shown in Fig 4D, PD98059, an inhibitor of the MEK1/2-ERK pathway, attenuated the enhancing effects of ATP on the IFN-β expression. It was also confirmed that the ATP-induced ERK phosphorylation was indeed inhibited in the presence of PD98059 (Fig 4E). Furthermore, the ATP-induced ERK phosphorylation was reduced in the P2X7R knockdown cells and also inhibited by BAPTA-AM (Fig 4F and 4G). These results suggest that ATP sensing by P2X7R and the following Ca2+ influx and ERK phosphorylation may be potential pathways for enhancing the LPS-induced IFN-β expression, leading to the increased iNOS expression and NO production.
Inhibitory effects of polyphenols on ATP/P2X7R signaling
We next investigated the inhibitory effects of natural polyphenols on the ATP/P2X7R signaling by measuring the Ca2+ influx as an indicator of the P2X7R activation. Among the 42 polyphenols (listed in S2 Table), we found that, as well as brilliant blue G (BBG), a P2X7R antagonist [54], baicalein and resveratrol exhibited the most significant inhibitory effects on the ATP-induced Ca2+ influx (Fig 5A). It was also confirmed that these two polyphenols inhibited the P2X7R activation in dose-dependent manners (Fig 5B). On the other hand, inhibitory effects of these polyphenols on the ATP-induced ERK phosphorylation could not be observed (Figure A in S2 Fig). This may be due to the fact that these polyphenols induced ERK phosphorylation regardless of the presence or absence of ATP. These results suggest that specific polyphenols could target the ATP/P2X7R signaling, probably by antagonizing ATP and suppressing the Ca2+ influx.
Anti-inflammatory effects of baicalein through interfering ATP/P2X7R signaling
The results shown above indicated that ATP facilitates inflammatory responses through P2X7R, and that several polyphenols, such as baicalein and resveratrol, inhibit ATP/P2X7R signaling. We next investigated whether these polyphenols could indeed attenuate inflammation through inhibiting ATP/P2X7R signaling. Pre-treatment of baicalein or resveratrol inhibited the LPS/ATP-induced NO production in dose-dependent manners (Fig 6A). We confirmed that these polyphenols did not affect the cell viability under this experimental condition (Figure B in S2 Fig). As reported in many papers, polyphenols could inhibit the LPS/TLR4 signaling [32,38]. Therefore, the inhibitory effects of these polyphenols on NO production were conceivably due to the inhibition of not only the ATP/P2X7R signaling but also the LPS/TLR4 signaling. Thus, to investigate whether the inhibition of the ATP/P2X7R signaling by these polyphenols definitely confers the anti-inflammatory effects, we examined the effects of baicalein and resveratrol on the IFN-β expression, more upstream than the NO production. As shown in Fig 6B, baicalein inhibited the ATP-enhanced IFN-β expression at a lower concentration that did not affect the expression induced by LPS alone, whereas resveratrol rather induced IFN-β expression under this condition.
To further propose that the polyphenols could attenuate the ATP/P2X7R signaling, we then examined the inhibitory effects of baicalein and resveratrol on the secretion of IL-1β, an LPS-induced pro-inflammatory cytokine, the production of which is tightly regulated and specifically triggered by ATP as secondary stimuli [55]. As shown in Fig 6C, IL-1β was hardly detectable in cultured supernatants of the cells treated with the vehicle and LPS alone. On the other hand, the secretion of IL-1β was significantly induced upon ATP treatment 4 h after the LPS treatment. The secretion was significantly inhibited in the presence of BBG, showing that ATP sensing by P2X7R specifically contributes to IL-1β secretion. Under this experimental condition, the IL-1β secretion was significantly inhibited by pre-treatment with baicalein for 10 min before the ATP stimulation. On the other hand, similar to the results on IFN-β expression, resveratrol did not inhibit the IL-1β secretion. These results demonstrated that baicalein could be a potential candidate as a natural inhibitor of the ATP/P2X7R signaling.
Discussion
Inflammation is an important defense response in noxious conditions, such as infection, whereas abnormal inflammatory responses are shown to cause various diseases. LPS-induced inflammation is a well-studied model of infection and diseases, therefore, the molecular signaling through the TLR4 receptor could be a target for therapy. Recent studies have shown that released endogenous molecules from damaged or immune cells, called DAMPs, are also implicated in the activation of inflammatory responses. In this study, we investigated the molecular actions of extracellular ATP, considered as one of the prototypical DAMP molecules [56,57], on the LPS-induced macrophage inflammation. Based on the molecular actions of ATP, to develop a new strategy for the prevention of inflammatory diseases, we evaluated the inhibitory effects of natural polyphenols on ATP signaling. We first observed that NO production and iNOS expression in the LPS-stimulated J774.1 macrophages were enhanced by ATP (Fig 1A–1C). It has been reported that the extracellular ATP is rapidly degraded to ADP and AMP, whereas the LPS-induced NO production was not enhanced by these degradation products (Figure D in S1 Fig). Although we did not examine the actual enzyme activity of ectonucleotidases in J774.1 cells, we scarcely detected the degradation products of ATP by a liquid chromatography-tandem mass spectrometry in culture supernatants of J774.1 treated with 1 mM ATP, strongly suggesting that the effects of ATP in this study reflect the action of ATP itself. NO has been recognized not only as a vasodilator and a neurotransmitter, but also as anti-microbial, anti-tumor, tissue-damaging, and immune-modulating products in the immune system. NO plays a dual role during inflammation by exerting protective and toxic effects in parallel, and this dual effect has been explained as being dependent on the NO concentration [58–60]. Although we did not investigate the phenotypic consequences of the up-regulated NO production, we speculated that LPS/ATP-enhanced NO production might lead to disorders and diseases associated with excess inflammation.
We then investigated the activation of the transcription factors and signal transduction pathways involved in the LPS/ATP-induced iNOS expression. We observed that the LPS-induced IFN-β expression and the downstream STAT1 phosphorylation were up-regulated by ATP. STAT1 has been reported to be an essential transcription factor for the iNOS expression [43]. In addition, we found that ATP facilitated the LPS-induced TLR4 signaling, such as the NF-κB and MAPK pathways, and the phosphorylation of IRF-3, the transcription factor for IFN-β. TLR4 signaling is generally separated into the myeloid differentiation primary response gene 88 (MyD88)-dependent pathway for expression of the pro-inflammatory cytokines and the TIR domain-containing adaptor protein-inducing IFN-β (TRIF)-dependent pathway for expression of the Type I IFNs. It has been suggested that NF-κB and MAPK could be activated through both pathways and that IRF-3 could be through the TRIF-dependent pathway [61,62]. Our results indicated that ATP accelerated both pathways, leading to the activation of the iNOS transcription factors. We also found that the mRNA expression of other LPS-induced inflammatory mediators, such as tumor necrosis factor-α (TNF-α), cyclooxygenase-2 (COX-2), IL-6, IL-10, and IL-1β, were also affected in the presence of ATP (S3 Fig). These results suggested that ATP accelerated upstream pathways in the LPS/TLR4 signaling resulting in perturbation of the downstream mRNA expression of iNOS and other inflammatory mediators.
We focused on the involvement of P2X7R regarding the effects of ATP because P2X7R is highly expressed in immune cells and responds to higher ATP concentrations. Using the siRNA-induced knockdown and antagonist of P2X7R, we demonstrated that P2X7R is indeed involved in the ATP-enhanced inflammatory responses. Our results that the LPS-induced NO production without ATP addition was also reduced in the P2X7R knockdown cells (Fig 3A) suggest the activation of the P2X7R signaling during stimulation with only LPS. Although similar observations that ATP or the P2X7R agonist enhanced LPS-induced inflammatory responses including IFN-β expression have been reported [63,64], our results clearly revealed the molecular actions of ATP through P2X7R, leading to enhanced NO production. For example, we demonstrated that ATP stimulated the Ca2+ influx and activated intracellular signaling, such as ERK phosphorylation, which subsequently enhanced the expression of the LPS-induced IFN-β expression and NO production. In addition, the LPS/ATP-enhanced IFN-β expression was reduced by BAPTA-AM and PD98059 (Figs 3 and 4), suggesting that the intracellular Ca2+ and the activation of MEK/ERK are both important for the LPS/ATP-induced inflammatory signaling. It has been reported that ATP binding to the extracellular loop of P2X7R results in not only channel opening but also structural and/or functional changes of the intracellular proteins or membrane lipids, such as calmodulin, heat shock proteins, cytoskeletal proteins, and phosphatidylinositol 4,5-phosphate, all of which bind to the C-terminal of P2X7R [65–67]. Therefore, these observations suggest that both the Ca2+-dependent and -independent signals of P2X7R are potential pathways in the ATP-induced inflammatory regulation.
Many studies, including the pre-clinical studies, have suggested that P2X7R could be therapeutically important targets because of the involvement in inflammatory diseases and pain. Although various negative or positive modulators of the P2X7R activation including natural products, synthetic molecules, and monoclonal antibodies, have been demonstrated, there is no approved medicine in clinical use [30,68–70]. In addition, little is known about the beneficial effects of dietary compounds targeting P2X7R [29]. Therefore, to prevent ATP/P2X7R-mediated abnormal inflammation, we explored the inhibitory effects of polyphenols, the largest group of phytochemicals, on the ATP/P2X7R signaling. We then found that a flavonoid baicalein (5,6,7-trihydroxyflavone) and a stilbenoid resveratrol significantly inhibited the ATP/P2X7R-mediated Ca2+ influx (Fig 5). We further investigated the effects of baicalein and resveratrol on the LPS/ATP-induced inflammation, and found that, as expected, these polyphenols indeed inhibited the LPS/ATP-induced NO production (Fig 6A). However, at least under this experimental condition, we could not distinguish whether these polyphenols modulated the LPS/TLR4 signaling or ATP/P2X7R signaling because many reports have demonstrated the inhibitory effects of polyphenols on the TLR4 signaling. For instance, resveratrol inhibits the kinase activity of TANK binding kinase 1 associating with TRIF, which is the TLR4 downstream component, resulting in decreasing the NF-κB and IRF-3 activation [71,72]. Another study also reported that quercetin inhibits the Src- and Syk-mediated PI3K phosphorylation and subsequent TLR4/MyD88/PI3K complex formation, resulting in the reduced activation of downstream signaling [73]. Therefore, to elucidate that the inhibition of the ATP/P2X7R signaling by baicalein or resveratrol definitely contributes to the anti-inflammatory or therapeutic effects, we evaluated the effects of these polyphenols on IL-1β secretion. In culture experiments, IL-1β is neither matured nor secreted by the treatment with only LPS. It is generally recognized that ATP addition after a few hours of LPS stimulation triggered inflammasome activation leading to the formation and secretion of the matured IL-1β [18,55]. We then examined the effects of two polyphenols on the ATP-triggered IL-1β secretion and found that the IL-1β secretion was significantly inhibited by baicalein, but unfortunately, not by resveratrol (Fig 6C). Although we did not investigate the activation of inflammasome in this study, the result strongly suggested that baicalein reduced the maturation and secretion of IL-1β through inhibition of the ATP/P2X7R signaling. Effects of antagonizing ATP/P2X7R signaling by baicalein or other natural products on inflammatory responses in vivo have not yet been determined within this study. Utilization of P2X7R-deficient mice in the near future will clarify the involvements of ATP in inflammatory responses and the possible interactions between natural polyphenols and P2X7R in vivo.
Baicalein and its glucuronide (baicalin), the major components of Scutellaria baicalensis Georgi, a popular herb used in traditional Chinese herbal medicine, are shown to prevent cancer, inflammation, cardiovascular diseases, and hypertension [74]. He et al. reported that baicalein inhibited TLR4 expression, NF-κB, and MAPK signal pathways and subsequently reduced the levels of pro-inflammatory cytokines [75]. Our current results also proposed a new health-beneficial activity of baicalein through inhibition of ATP/P2X7R signaling. Although the inhibitory effect of baicalin was not examined in this study, we previously reported that the glucuronides of flavonoids could be deconjugated into the aglycones by macrophages, resulting in increased anti-inflammatory activity as compared to the parent glucuronides [76]. Therefore, interaction between macrophages and baicalin could result in the inhibitory effect on the ATP/P2X7R signaling, similar to the action of the aglycone baicalein. On the other hand, in spite of the inhibitory effect on ATP-induced Ca2+ influx, resveratrol did not inhibit ATP-enhanced IFN-β expression and IL-1β secretion (Fig 6B and 6C). Resveratrol rather induced LPS/ATP-induced IFN-β expression. Although we predicted that both baicalein and resveratrol could also inhibit the ATP/P2X7R-mediated ERK phosphorylation, as well as Ca2+ influx, these polyphenols, especially resveratrol, conversely enhanced the ATP-induced ERK phosphorylation (Figure A in S2 Fig). Similarly, several papers also demonstrated the ERK activation by polyphenols [77–80]. Within this study, it is still unclear how tight the link between Ca2+ influx and ERK phosphorylation is in the ATP signaling. Resveratrol, found in grape products such as red wine, has been shown to improve cardiovascular performance and extend the lifespans of non-mammals and mice [81]. However, we could not conclude that, at least from our observations, resveratrol is a potent inhibitor of ATP/P2X7R signaling.
Overall, our results indicated the potential preventive effects of baicalein on exacerbating the ATP/P2X7R signaling, not only LPS signaling, under noxious or abnormal conditions. We demonstrated the molecular actions of the extracellular ATP through P2X7R on the LPS signaling, resulting in excess inflammation, and also proposed a new strategy for the prevention of excess inflammation by inhibiting the ATP/P2X7R signaling using natural polyphenols, such as baicalein. As well as ATP/P2X7R, involvements of other pairs of DAMPs/receptors such as advanced glycation end-product/RAGEs and β-amyloid, in the inflammatory responses have been suggested [82–83]. Therefore, our conclusion is that the ATP/P2X7R signaling and other DAMPs signaling could be a new potential target of drugs and natural compounds including polyphenols for the prevention of disorders and diseases associated with excess inflammation.
Supporting information
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This work was supported by JSPS KAKENHI Grant Number 26292069, 15K14730.
References
- 1.Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010. March 19;140(6):771–6. 10.1016/j.cell.2010.03.006 [DOI] [PubMed] [Google Scholar]
- 2.Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008. July 24;454(7203):428–35. 10.1038/nature07201 [DOI] [PubMed] [Google Scholar]
- 3.Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med. 2000. July 17;192(2):227–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011. February;11(2):98–107. 10.1038/nri2925 [DOI] [PubMed] [Google Scholar]
- 5.Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014. September;16(9):435 10.1007/s11883-014-0435-z [DOI] [PubMed] [Google Scholar]
- 6.Libby P. Inflammation in atherosclerosis. Nature. 2002. Des 19–26;420(6917):868–74. 10.1038/nature01323 [DOI] [PubMed] [Google Scholar]
- 7.Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002. March 5;105(9):1135–43. [DOI] [PubMed] [Google Scholar]
- 8.Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Inflammation and Alzheimer’s disease. Arch Pharm Res. 2010. October;33(10):1539–56. 10.1007/s12272-010-1006-7 [DOI] [PubMed] [Google Scholar]
- 9.Bagyinszky E, Giau VV, Shim K, Suk K, An SSA, Kim S. Role of inflammatory molecules in the Alzheimer’s disease progression and diagnosis. J Neurol Sci. 2017. May 15;376:242–254. 10.1016/j.jns.2017.03.031 [DOI] [PubMed] [Google Scholar]
- 10.Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010. March 19;140(6):883–99. 10.1016/j.cell.2010.01.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vénéreau E, Ceriotti C, Bianchi ME. DAMPs from Cell Death to New Life. Front Immunol. 2015. August 18;6:422 10.3389/fimmu.2015.00422 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;2010:672395 10.1155/2010/672395 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Yang H, Wang H, Ju Z, Ragab AA, Lundbäck P, Long W, et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med. 2015. January 12;212(1):5–14. 10.1084/jem.20141318 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med. 2012. December 13;367(24):2322–33. 10.1056/NEJMra1205750 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 1997. April 21;185(8):1481–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lohman AW, Isakson BE. Differentiating connexin hemichannels and pannexin channels in cellular ATP release. FEBS Lett. 2014. April 17;588(8):1379–88. 10.1016/j.febslet.2014.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang Y, Martins I, Ma Y, Kepp O, Galluzzi L, Kroemer G. Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy. 2013. October;9(10):1624–5. 10.4161/auto.25873 [DOI] [PubMed] [Google Scholar]
- 18.Giuliani AL, Sarti AC, Falzoni S, Di Virgilio F. The P2X7 Receptor-Interleukin-1 Liaison. Front Pharmacol. 2017. March 16;8:123 10.3389/fphar.2017.00123 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998. September;50(3):413–92. [PubMed] [Google Scholar]
- 20.Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009. September 10;461(7261):282–6. 10.1038/nature08296 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lommatzsch M, Cicko S, Müller T, Lucattelli M, Bratke K, Stoll P, et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010. May 1;181(9):928–34. 10.1164/rccm.200910-1506OC [DOI] [PubMed] [Google Scholar]
- 22.Riteau N, Gasse P, Fauconnier L, Gombault A, Couegnat M, Fick L, et al. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med. 2010. September 15;182(6):774–83. 10.1164/rccm.201003-0359OC [DOI] [PubMed] [Google Scholar]
- 23.Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med. 2007. August;13(8):913–9. 10.1038/nm1617 [DOI] [PubMed] [Google Scholar]
- 24.Wan P, Liu X, Xiong Y, Ren Y, Chen J, Lu N, et al. Extracellular ATP mediates inflammatory responses in colitis via P2X7 receptor signaling. Sci Rep. 2016. January 7;6:19108 10.1038/srep19108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Portales-Cervantes L, Niño-Moreno P, Doníz-Padilla L, Baranda-Candido L, García-Hernández M, Salgado-Bustamante M, et al. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Hum Immunol. 2010. August;71(8):818–25. 10.1016/j.humimm.2010.05.008 [DOI] [PubMed] [Google Scholar]
- 26.Zanin RF, Bergamin LS, Morrone FB, Coutinho-Silva R, de Souza Wyse AT, Battastini AM. Pathological concentrations of homocysteine increases IL-1β production in macrophages in a P2X7, NF-κB, and erk-dependent manner. Purinergic Signal. 2015. December;11(4):463–70. 10.1007/s11302-015-9464-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Leyva-Grado VH, Ermler ME, Schotsaert M, Gonzalez MG, Gillespie V, Lim JK, et al. Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection. MBio. 2017. March 28;8(2):e00229–17. 10.1128/mBio.00229-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ryu JK, Jantaratnotai N, Serrano-Perez MC, McGeer PL, McLarnon JG. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model. J Neuropathol Exp Neurol. 2011. January;70(1):13–22. 10.1097/NEN.0b013e318201d4d4 [DOI] [PubMed] [Google Scholar]
- 29.Soares-Bezerra RJ, Calheiros AS, da Silva Ferreira NC, da Silva Frutuoso V, Alves LA. Natural Products as a Source for New Anti-Inflammatory and Analgesic Compounds through the Inhibition of Purinergic P2X Receptors. Pharmaceuticals (Basel). 2013. April 29;6(5):650–8. 10.3390/ph6050650 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Alves LA, Bezerra RJ, Faria RX, Ferreira LG, da Silva Frutuoso V. Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain. Molecules. 2013. September 5;18(9):10953–72. 10.3390/molecules180910953 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tangney CC, Rasmussen HE. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep. 2013. May;15(5):324 10.1007/s11883-013-0324-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Santangelo C, Varì R, Scazzocchio B, Di Benedetto R, Filesi C, Masella R. Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita. 2007;43(4):394–405. [PubMed] [Google Scholar]
- 33.Gupta SC, Tyagi AK, Deshmukh-Taskar P, Hinojosa M, Prasad S, Aggarwal BB. Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys. 2014. October 1;559:91–9. 10.1016/j.abb.2014.06.006 [DOI] [PubMed] [Google Scholar]
- 34.Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, et al. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res. 2008. February 1;68(3):946–55. 10.1158/0008-5472.CAN-07-3140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Youn HS, Lee JY, Saitoh SI, Miyake K, Kang KW, Choi YJ, et al. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharmacol. 2006. September 28;72(7):850–9. 10.1016/j.bcp.2006.06.021 [DOI] [PubMed] [Google Scholar]
- 36.Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther. 2001. January;296(1):181–7. [PubMed] [Google Scholar]
- 37.Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, et al. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol. 2007. November 15;179(10):7121–7. [DOI] [PubMed] [Google Scholar]
- 38.Prasad S, Phromnoi K, Yadav VR, Chaturvedi MM, Aggarwal BB. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med. 2010. August;76(11):1044–63. 10.1055/s-0030-1250111 [DOI] [PubMed] [Google Scholar]
- 39.Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, Braidy N, et al. Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation. Ageing Res Rev. 2017. July;36:11–19. 10.1016/j.arr.2017.02.004 [DOI] [PubMed] [Google Scholar]
- 40.Burnstock G, Boeynaems JM. Purinergic signalling and immune cells. Purinergic Signal. 2014. December;10(4):529–64. 10.1007/s11302-014-9427-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Antonioli L, Pacher P, Vizi ES, Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013. June;19(6):355–67. 10.1016/j.molmed.2013.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA. 1993. October 15;90(20):9730–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Farlik M, Reutterer B, Schindler C, Greten F, Vogl C, Müller M, et al. Nonconventional initiation complex assembly by STAT and NF-kappaB transcription factors regulates nitric oxide synthase expression. Immunity. 2010. July 23;33(1):25–34. 10.1016/j.immuni.2010.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, Takaoka A, et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun. 2003. July 11;306(4):860–6. [DOI] [PubMed] [Google Scholar]
- 45.Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS. Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev. 2011. September;63(3):641–83. 10.1124/pr.110.003129 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Jacobson KA, Müller CE. Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology. 2016. May;104:31–49. 10.1016/j.neuropharm.2015.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cekic C, Linden J. Purinergic regulation of the immune system. Nat Rev Immunol. 2016. March;16(3):177–92. 10.1038/nri.2016.4 [DOI] [PubMed] [Google Scholar]
- 48.Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol. 2011. March;11(3):201–12. 10.1038/nri2938 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Feske S, Skolnik EY, Prakriya M. Ion channels and transporters in lymphocyte function and immunity. Nat Rev Immunol. 2012. June 15;12(7):532–47. 10.1038/nri3233 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity. 2012. February 24;36(2):166–74. 10.1016/j.immuni.2012.01.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Gendron FP, Neary JT, Theiss PM, Sun GY, Gonzalez FA, Weisman GA. Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am J Physiol Cell Physiol. 2003. February;284(2):C571–81. 10.1152/ajpcell.00286.2002 [DOI] [PubMed] [Google Scholar]
- 52.Tsao HK, Chiu PH, Sun SH. PKC-dependent ERK phosphorylation is essential for P2X7 receptor-mediated neuronal differentiation of neural progenitor cells. Cell Death Dis. 2013. August 1;4:e751 10.1038/cddis.2013.274 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.da Cruz CM, Ventura AL, Schachter J, Costa-Junior HM, da Silva Souza HA, Gomes FR, et al. Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation. Br J Pharmacol. 2006. February;147(3):324–34. 10.1038/sj.bjp.0706559 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Jiang LH, Mackenzie AB, North RA, Surprenant A. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol. 2000. July;58(1):82–8. [PubMed] [Google Scholar]
- 55.Pelegrin P, Barroso-Gutierrez C, Surprenant A. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol. 2008. June 1;180(11):7147–57. [DOI] [PubMed] [Google Scholar]
- 56.Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5’-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006. November;112(2):358–404. 10.1016/j.pharmthera.2005.04.013 [DOI] [PubMed] [Google Scholar]
- 57.Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010. December;10(12):826–37. 10.1038/nri2873 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci. 2000. July;21(7):249–52. [DOI] [PubMed] [Google Scholar]
- 59.Moncada S, Higgs A, Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev. 1997. June;49(2):137–42. [PubMed] [Google Scholar]
- 60.Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001. October;2(10):907–16. 10.1038/ni1001-907 [DOI] [PubMed] [Google Scholar]
- 61.Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008. May;42(2):145–51. 10.1016/j.cyto.2008.01.006 [DOI] [PubMed] [Google Scholar]
- 62.Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010. May;11(5):373–84. 10.1038/ni.1863 [DOI] [PubMed] [Google Scholar]
- 63.Gavala ML, Liu YP, Lenertz LY, Zeng L, Blanchette JB, Guadarrama AG, et al. Nucleotide receptor P2RX7 stimulation enhances LPS-induced interferon-β production in murine macrophages. J Leukoc Biol. 2013. October;94(4):759–68. 10.1189/jlb.0712351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Fujimoto Y, Nakatani N, Kubo T, Semi Y, Yoshida N, Nakajima H, et al. Adenosine and ATP affect LPS-induced cytokine production in canine macrophage cell line DH82 cells. J Vet Med Sci. 2012. January;74(1):27–34. [DOI] [PubMed] [Google Scholar]
- 65.Kim M, Jiang LH, Wilson HL, North RA, Surprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 2001. November 15;20(22):6347–58. 10.1093/emboj/20.22.6347 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Costa-Junior HM, Marques-da-Silva C, Vieira FS, Monção-Ribeiro LC, Coutinho-Silva R. Lipid metabolism modulation by the P2X7 receptor in the immune system and during the course of infection: new insights into the old view. Purinergic Signal. 2011. December;7(4):381–92. 10.1007/s11302-011-9255-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Costa-Junior HM, Sarmento Vieira F, Coutinho-Silva R. C terminus of the P2X7 receptor: treasure hunting. Purinergic Signal. 2011. March;7(1):7–19. 10.1007/s11302-011-9215-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.North RA, Jarvis MF. P2X receptors as drug targets. Mol Pharmacol. 2013. April;83(4):759–69. 10.1124/mol.112.083758 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Bartlett R, Stokes L, Sluyter R. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev. 2014. July;66(3):638–75. 10.1124/pr.113.008003 [DOI] [PubMed] [Google Scholar]
- 70.Mehta N, Kaur M, Singh M, Chand S, Vyas B, Silakari P, et al. Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy. Bioorg Med Chem. 2014. January 1;22(1):54–88. 10.1016/j.bmc.2013.10.054 [DOI] [PubMed] [Google Scholar]
- 71.Zhao L, Lee JY, Hwang DH. Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals. Nutr Rev. 2011. June;69(6):310–20. 10.1111/j.1753-4887.2011.00394.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol. 2003. October 15;171(8):4304–10. [DOI] [PubMed] [Google Scholar]
- 73.Endale M, Park SC, Kim S, Kim SH, Yang Y, Cho JY, et al. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology. 2013. December;218(12):1452–67. 10.1016/j.imbio.2013.04.019 [DOI] [PubMed] [Google Scholar]
- 74.Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev. 2009. February;35(1):57–68. 10.1016/j.ctrv.2008.09.005 [DOI] [PubMed] [Google Scholar]
- 75.He X, Wei Z, Zhou E, Chen L, Kou J, Wang J, et al. Baicalein attenuates inflammatory responses by suppressing TLR4 mediated NF-κB and MAPK signaling pathways in LPS-induced mastitis in mice. Int Immunopharmacol. 2015. September;28(1):470–6. 10.1016/j.intimp.2015.07.012 [DOI] [PubMed] [Google Scholar]
- 76.Ishisaka A, Kawabata K, Miki S, Shiba Y, Minekawa S, Nishikawa T, et al. Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS One. 2013. November 19;8(11):e80843 10.1371/journal.pone.0080843 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Chen CY, Jang JH, Li MH, Surh YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun. 2005. June 17;331(4):993–1000. 10.1016/j.bbrc.2005.03.237 [DOI] [PubMed] [Google Scholar]
- 78.Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, Surh YJ. (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys. 2008. August 15;476(2):171–7. 10.1016/j.abb.2008.04.003 [DOI] [PubMed] [Google Scholar]
- 79.Zhao M, Chen J, Zhu P, Fujino M, Takahara T, Toyama S, et al. Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells. Int Immunopharmacol. 2015. October;28(2):938–44. 10.1016/j.intimp.2015.04.032 [DOI] [PubMed] [Google Scholar]
- 80.Lin CW, Wu MJ, Liu IY, Su JD, Yen JH. Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERK-dependent induction of Nrf2-driven HO-1 expression. J Agric Food Chem. 2010. April 14;58(7):4477–86. 10.1021/jf904061x [DOI] [PubMed] [Google Scholar]
- 81.Bhullar KS, Hubbard BP. Lifespan and healthspan extension by resveratrol. Biochim Biophys Acta. 2015. June;1852(6):1209–18. 10.1016/j.bbadis.2015.01.012 [DOI] [PubMed] [Google Scholar]
- 82.Chuah YK, Basir R; Talib H, Tie TH, Nordin N. Receptor for advanced glycation end products and its involvement in inflammatory diseases. Int J Inflam. 2013. September 11; 2013:403460 10.1155/2013/403460 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Gasic-Milenkovic J, Dukic-Stefanovic S, Deuther-Conrad W, Gárther U, Münch G. β-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-γ and ‘advanced glycation endproducts’ in a murine microglia cell line. Eur J Neurosci. 2003. February; 17(4):813–21. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.